Skip to main content

Table 3 Best overall response and disease control rate per RECIST (Full Analysis Population)

From: A preliminary randomised controlled study of short-term Antrodia cinnamomea treatment combined with chemotherapy for patients with advanced cancer

 

Chemotherapy + AC (n = 17)

Chemotherapy + placebo (n = 20)

p-value

Best overall response, No. (%)a

Complete response (CR)

0

0

 

Partial response (PR)

3 (17.6)

3 (15)

 

Stable disease (SD)

4 (23.5)

8 (40)

 

Progressive disease (PD)

6 (35.3)

5 (25)

 

Unknown

4 (23.5)

4 (20)

 

Disease control rate (CR + PR + SD)

7 (41.2)

11 (55)

0.33

  1. aProportion of patients whose best overall response is complete response, partial response, or stable disease according to RECIST (Response Evaluation Criteria in Solid Tumors)